High levels of PTHrP expressed by bone-metastatic tumor cells bind to PTHR1 on osteoblasts, inducing these cells to release RANKL, which in turn binds to RANK on immature osteoclasts and promotes osteoclastogenesis [15]. Here, PTHLH is linked to neoplasm.